Psychiatric disorders are common in genPsychiatric disorders are common in general practice and the general practitioner eral practice and the general practitioner has a pivotal role in the recognition and has a pivotal role in the recognition and subsequent treatment of psychiatric disorsubsequent treatment of psychiatric disorders. Although psychiatric attention tends ders. Although psychiatric attention tends to focus on anxiety and depressive disto focus on anxiety and depressive disorders, these disorders are not the most orders, these disorders are not the most prevalent in general practice. Fink prevalent in general practice. Fink et al et al (1999) reported a prevalence of somato-(1999) reported a prevalence of somatoform disorders as high as 30.3%. The coform disorders as high as 30.3%. The comorbidity of somatoform disorders with morbidity of somatoform disorders with anxiety and depressive disorders is high anxiety and depressive disorders is high (Maier & Falkai, 1999) and the burden (Maier & Falkai, 1999) and the burden of illness may be substantial (Kroenke of illness may be substantial (Kroenke et et al al, 1997) . A critical review demonstrated , 1997) . A critical review demonstrated that cognitive-behavioural therapy can be that cognitive-behavioural therapy can be effective in treating patients with somatoeffective in treating patients with somatoform disorders (Kroenke & Swindle, form disorders (Kroenke & Swindle, 2000) . Few comprehensive studies have 2000). Few comprehensive studies have focused on an accurate quantification of focused on an accurate quantification of clinically relevant disorders. The aim of clinically relevant disorders. The aim of the present study was to quantify the the present study was to quantify the prevalence of somatoform disorders and prevalence of somatoform disorders and comorbidity with anxiety and depressive comorbidity with anxiety and depressive disorders in primary care using DSM-IV disorders in primary care using DSM-IV criteria (American Psychiatric Association, criteria (American Psychiatric Association, 1994) , with a particular emphasis on 1994), with a particular emphasis on functional impairment. functional impairment.
METHOD METHOD

Study design Study design
The somatisation study of the University of The somatisation study of the University of Leiden (SOUL study) was designed as a Leiden (SOUL study) was designed as a two-stage prevalence study. In the initial two-stage prevalence study. In the initial stage, screening questionnaires were used stage, screening questionnaires were used to identify high-risk patients. In the second to identify high-risk patients. In the second stage, all high-risk patients and a sample stage, all high-risk patients and a sample of 15% of the low-risk patients were of 15% of the low-risk patients were invited for a psychiatric diagnostic interinvited for a psychiatric diagnostic interview. After a follow-up of 6 months, parview. After a follow-up of 6 months, participants with a somatoform disorder will ticipants with a somatoform disorder will be included in a subsequent controlled be included in a subsequent controlled treatment study of cognitive-behavioural treatment study of cognitive-behavioural therapy given by their own general therapy given by their own general practitioner (not reported here). practitioner (not reported here).
Setting Setting
The study took place in eight universityThe study took place in eight universityaffiliated affiliated general practices in The Nethergeneral practices in The Netherlands. The age and gender distributions lands. The age and gender distributions are comparable to those of the Dutch popuare comparable to those of the Dutch population. The electronic medical records of all lation. The electronic medical records of all patients were available through the central patients were available through the central database (Registratie Netwerk Universitaire database (Registratie Netwerk Universitaire Huisartspraktijken Leiden En Omstreken Huisartspraktijken Leiden En Omstreken (RNUH-LEO)) of the family practice regis-(RNUH-LEO)) of the family practice registration network of Leiden (13 practices). tration network of Leiden (13 practices). The database contains diagnostic codings The database contains diagnostic codings according to the International Classificaaccording to the International Classification of Primary Care (ICPC; Lamberts & tion of Primary Care (ICPC; Lamberts & Wood, 1990) for each consultation. Wood, 1990) for each consultation.
Patients Patients
Between April 2000 and December 2001 a Between April 2000 and December 2001 a sample of 1778 attendees, aged 25-80 sample of 1778 attendees, aged 25-80 years, was sent the screening questionyears, was sent the screening questionnaires by mail. After 2 weeks those who naires by mail. After 2 weeks those who had not responded were sent a reminder, had not responded were sent a reminder, including the questionnaires. For each genincluding the questionnaires. For each general practice the sample consisted of all eral practice the sample consisted of all consecutive patients on 13-30 arbitrary consecutive patients on 13-30 arbitrary days within a 3-month period. To avoid days within a 3-month period. To avoid problems with language, the study was problems with language, the study was limited to Dutch natives. Patients were limited to Dutch natives. Patients were not included if they were unable to particinot included if they were unable to participate in an interview because of difficulties pate in an interview because of difficulties such as deafness, aphasia or cognitive imsuch as deafness, aphasia or cognitive impairment. A total of 1046 patients (59%) pairment. A total of 1046 patients (59%) returned the questionnaire and indicated returned the questionnaire and indicated that they were willing to participate. Data that they were willing to participate. Data from the RNUH-LEO database allowed from the RNUH-LEO database allowed fairly detailed analyses of non-response fairly detailed analyses of non-response characteristics. Non-response analyses characteristics. Non-response analyses showed that male patients of 25-44 years showed that male patients of 25-44 years of age in particular were less willing to of age in particular were less willing to participate (response of 46%). When comparticipate (response of 46%). When comparing reasons for consultation in the 3 paring reasons for consultation in the 3 months prior to selection, non-responders months prior to selection, non-responders did not have more psychological problems did not have more psychological problems (ICPC classification chapter P: 14%) than (ICPC classification chapter P: 14%) than responders but they did have slightly more responders but they did have slightly more social problems (ICPC classification chapsocial problems (ICPC classification chapter Z: 7% ter Z: 7% v v. 4%). Approximately 50% . 4%). Approximately 50% of both non-responders and responders of both non-responders and responders consulted a general practitioner five or consulted a general practitioner five or more times in the year prior to selection. more times in the year prior to selection. Logistic regression modelling showed that Logistic regression modelling showed that after correction for age and gender (which after correction for age and gender (which both still have a significant effect) the only both still have a significant effect) the only other variable with a significant effect was other variable with a significant effect was a social reason for encounter (odds a social reason for encounter (odds ratio ratio¼0.6). Social problems are mainly 0.6). Social problems are mainly problems in the relationship with a partner problems in the relationship with a partner or other, mourning and problems related or other, mourning and problems related to the work situation. to the work situation.
Participants completed the SF-36 funcParticipants completed the SF-36 functional limitation questionnaire (Aaronson tional limitation questionnaire (Aaronson et al et al, 1998) as a measure of functional im-, 1998) as a measure of functional impairment, the Hospital Anxiety and Deprespairment, the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, sion Scale (HADS; Zigmond & Snaith, 1983) as a measure of anxiety and depres-1983) as a measure of anxiety and depression and the Physical Symptom Checklist sion and the Physical Symptom Checklist (PSC; available from the authors on re-(PSC; available from the authors on request) to quantify the number of reported quest) to quantify the number of reported physical symptoms. physical symptoms.
The first two questionnaires have been The first two questionnaires have been validated extensively and described validated extensively and described sufficiently elsewhere. In general medical sufficiently elsewhere. In general medical out-patients the total HADS scale has been out-patients the total HADS scale has been validated for detecting psychiatric disvalidated for detecting psychiatric disorders: a cut-off point of 15 gave a senorders: a cut-off point of 15 gave a sensitivity of 74% and a specificity of 84% sitivity of 74% and a specificity of 84% (Spinhoven (Spinhoven et al et al, 1997) . The PSC is a , 1997). The PSC is a checklist of 55 physical symptoms that checklist of 55 physical symptoms that were mentioned in the DSM-III classificawere mentioned in the DSM-III classification (American Psychiatric Association, tion (American Psychiatric Association, 1980) and includes a broad array of 1980) and includes a broad array of symptoms covering most organ systems. symptoms covering most organ systems. The presence of symptoms is rated on a The presence of symptoms is rated on a severity scale of 0-3 for the preceding severity scale of 0-3 for the preceding week. A symptom is rated as present for week. A symptom is rated as present for scores 2 and 3. The total score represents scores 2 and 3. The total score represents the sum of the number of symptoms that the sum of the number of symptoms that are endorsed. In previous studies physical are endorsed. In previous studies physical symptoms were a useful severity indicator symptoms were a useful severity indicator of somatoform disorders and a fair predicof somatoform disorders and a fair predictor of medical utilisation (Van Hemert tor of medical utilisation (Van Hemert et al et al, 1993; Kroenke , 1993; Kroenke et al et al, 1994; Speckens , 1994; Speckens et al et al, 1996) . , 1996).
High-risk sample High-risk sample
A total score of 15 or more on the HADS or A total score of 15 or more on the HADS or a score of 5 or more on the PSC defined the a score of 5 or more on the PSC defined the high-risk sample, which is 48% of the total high-risk sample, which is 48% of the total sample. Of the 506 high-risk patients, 190 sample. Of the 506 high-risk patients, 190 patients screened positive on both the patients screened positive on both the HADS and the PSC, 265 patients screened HADS and the PSC, 265 patients screened positive only on the PSC and 51 patients positive only on the PSC and 51 patients screened positive only on the HADS. The screened positive only on the HADS. The choice of instruments and cut-off values choice of instruments and cut-off values for the high-risk sample are somewhat arbifor the high-risk sample are somewhat arbitrary because a sample of low-risk patients trary because a sample of low-risk patients was interviewed as well. The procedure was interviewed as well. The procedure merely aimed at increasing the number of merely aimed at increasing the number of interview positives for a subsequent treatinterview positives for a subsequent treatment study without affecting the prevalence ment study without affecting the prevalence estimate. estimate.
Diagnostic interview Diagnostic interview
Of all the high-risk patients, 80% When doubt remained, the symptom was When doubt remained, the symptom was regarded as 'explained'. The scoring algoregarded as 'explained'. The scoring algorithm needed to be modified slightly to rithm needed to be modified slightly to allow separate and accurate diagnoses of allow separate and accurate diagnoses of hypochondriasis and somatisation disorder hypochondriasis and somatisation disorder according to the criteria of DSM-IV. The according to the criteria of DSM-IV. The modifications were reported to the World modifications were reported to the World Health Organization task force that is Health Organization task force that is developing the SCAN. Because the overlap developing the SCAN. Because the overlap between somatoform disorders and anxiety between somatoform disorders and anxiety and depressive disorders is the object of this and depressive disorders is the object of this study, hierarchical rules between these study, hierarchical rules between these disorders were not applied. Within the disorders were not applied. Within the DSM-IV chapters the hierarchical rules DSM-IV chapters the hierarchical rules were preserved. All chronic somatoform were preserved. All chronic somatoform disorders were diagnosed (duration of at disorders were diagnosed (duration of at least 6 months): both acute pain disorder least 6 months): both acute pain disorder and somatoform disorder not otherwise and somatoform disorder not otherwise specified were excluded. specified were excluded.
An important modification of DSM-IV An important modification of DSM-IV (compared with its predecessors) is that a (compared with its predecessors) is that a severity criterion of 'significant clinical disseverity criterion of 'significant clinical distress or functional impairment' has been tress or functional impairment' has been included in most Axis I disorders. The disincluded in most Axis I disorders. The distinction between Axis I and Axis V has tinction between Axis I and Axis V has become blurred. From a clinical point of become blurred. From a clinical point of view this modification is well justified, but view this modification is well justified, but from an epidemiological point of view the from an epidemiological point of view the modification introduces an element of submodification introduces an element of subjectivity in the diagnostic process and comjectivity in the diagnostic process and comparisons with previous studies may have parisons with previous studies may have become hampered. We took meticulous become hampered. We took meticulous care to rate this item separately for each care to rate this item separately for each diagnosis throughout all interviews. To diagnosis throughout all interviews. To analyse the influence of this criterion, the analyse the influence of this criterion, the prevalence rates were re-analysed using all prevalence rates were re-analysed using all criteria of symptoms and duration, with criteria of symptoms and duration, with the exception of the severity criterion. the exception of the severity criterion.
Analyses Analyses
Of the 404 high-risk patients interviewed, Of the 404 high-risk patients interviewed, 116 had a DSM-IV somatoform disorder, 116 had a DSM-IV somatoform disorder, 40 had an anxiety disorder and 34 had a 40 had an anxiety disorder and 34 had a depressive disorder. Of the 69 low-risk depressive disorder. Of the 69 low-risk patients, 3 had a somatoform disorder patients, 3 had a somatoform disorder and 1 had an anxiety disorder. All prevaand 1 had an anxiety disorder. All prevalence estimates and confidence limits were lence estimates and confidence limits were weighted for the sampling procedure weighted for the sampling procedure (Cochran, 1997) . To quantify the overlap (Cochran, 1997) . To quantify the overlap of somatoform disorders and anxiety and/ of somatoform disorders and anxiety and/ or depressive disorders, the weighted or depressive disorders, the weighted prevalence and confidence limits for the prevalence and confidence limits for the combinations are given. In addition, we combinations are given. In addition, we calculated the ratio that represents the faccalculated the ratio that represents the factor by which comorbidity exceeds chance tor by which comorbidity exceeds chance expectations: by taking the observed prevaexpectations: by taking the observed prevalence and dividing it by the prevalence lence and dividing it by the prevalence expected by chance. Analyses were conexpected by chance. Analyses were conducted using SPSS for Windows 11.0 and ducted using SPSS for Windows 11.0 and MsExcell 97 software. MsExcell 97 software.
RESULTS RESULTS
Prevalence estimates Prevalence estimates
An estimated prevalence of DSM-IV somaAn estimated prevalence of DSM-IV somatoform disorders of 16.1% was found in a toform disorders of 16.1% was found in a Dutch general practice consulting popuDutch general practice consulting population (Table 1) . The most common somalation (Table 1) . The most common somatoform disorder was the undifferentiated toform disorder was the undifferentiated somatoform disorder, with a prevalence of somatoform disorder, with a prevalence of 13.1%. These patients suffer from one or 13.1%. These patients suffer from one or more unexplained physical symptoms (e.g. more unexplained physical symptoms (e.g. fatigue, headache or gastrointestinal sympfatigue, headache or gastrointestinal symptoms) that cause clinically significant distoms) that cause clinically significant distress or impairment for at least 6 months. tress or impairment for at least 6 months. The prevalence of current anxiety disorders The prevalence of current anxiety disorders was 5.5% and of current depressive diswas 5.5% and of current depressive disorders was 4.1%. When the new DSM-IV orders was 4.1%. When the new DSM-IV criterion of moderate to severe clinical criterion of moderate to severe clinical impairment was ignored (for all diagnoses), impairment was ignored (for all diagnoses), the prevalence of somatoform disorders the prevalence of somatoform disorders increased from 16.1% to 21.9%, the prevaincreased from 16.1% to 21.9%, the prevalence of anxiety disorders increased from lence of anxiety disorders increased from 5.5% to 7.0% and the prevalence of de-5.5% to 7.0% and the prevalence of depressive disorders increased from 4.0% to pressive disorders increased from 4.0% to 6.8%. It must be noted that patients who 6.8%. It must be noted that patients who had no symptoms because of effective medhad no symptoms because of effective medical treatment were not diagnosed. This ical treatment were not diagnosed. This was a substantial group of patients: use of was a substantial group of patients: use of antidepressants without current significant antidepressants without current significant symptoms was present in 7.4% (95% CI symptoms was present in 7.4% (95% CI 4.8-9.9) of patients and use of anxiolytics 4.8-9.9) of patients and use of anxiolytics without current significant symptoms was without current significant symptoms was present in 4.5% (95% CI 2.5-6.4) of present in 4.5% (95% CI 2.5-6.4) of patients. patients.
The age and gender distributions of the The age and gender distributions of the prevalence figures are summarised in prevalence figures are summarised in Table 2 . The estimated prevalence of Table 2 . The estimated prevalence of somatoform disorders was much lower in somatoform disorders was much lower in patients aged 65 years and over. The same patients aged 65 years and over. The same was found for anxiety disorders and depreswas found for anxiety disorders and depressive disorders. Women tended to have more sive disorders. Women tended to have more somatoform disorders (no significant differsomatoform disorders (no significant difference). We found no gender differences for ence). We found no gender differences for anxiety disorders. Depressive disorders anxiety disorders. Depressive disorders were slightly but not significantly more were slightly but not significantly more prevalent in females. prevalent in females.
Comorbidity and functional Comorbidity and functional impairment impairment
The comorbidity of DSM-IV somatoform The comorbidity of DSM-IV somatoform disorders and anxiety or depressive disordisorders and anxiety or depressive disorders is considerable (Fig. 1) . The observed ders is considerable (Fig. 1) . The observed comorbidity of somatoform disorders and comorbidity of somatoform disorders and anxiety/depressive disorders was 4.2% anxiety/depressive disorders was 4.2% (95% CI 2.9-5.5). The expected percentage (95% CI 2.9-5.5). The expected percentage of comorbidity occurring only by chance of comorbidity occurring only by chance was 1.3% (95% CI 1.9-7.2). The obwas 1.3% (95% CI 1.9-7.2). The observed/expected ratio was 3.3 (95% CI served/expected ratio was 3.3 (95% CI 1.8-6.1). Of all patients with a somatoform 1.8-6.1). Of all patients with a somatoform disorder, 26% (95% CI 23-28) also had an disorder, 26% (95% CI 23-28) also had an anxiety and/or depressive disorder: 17% anxiety and/or depressive disorder: 17% (95% CI 12-23) had an anxiety disorder (95% CI 12-23) had an anxiety disorder and 17% (95% CI 12-23) had a depressive and 17% (95% CI 12-23) had a depressive disorder. Of all patients with an anxiety disorder. Of all patients with an anxiety and/or depressive disorder, 54% (95% CI and/or depressive disorder, 54% (95% CI 48-60) also had a somatoform disorder. 48-60) also had a somatoform disorder.
The symptoms and functional limitaThe symptoms and functional limitations of patients with a somatoform disortions of patients with a somatoform disorder together with an anxiety or depressive der together with an anxiety or depressive disorder are more severe: they add up when disorder are more severe: they add up when comorbidity is present (Table 3 ). In comorbidity is present (Table 3 ). In 4 7 2 4 7 2 1. Excluding acute pain disorder and somatoform disorders not otherwise specified. 1. Excluding acute pain disorder and somatoform disorders not otherwise specified. 2. DSM^IV criteria do not include overall judgement of impairment; the two prevalence estimates are identical. 2. DSM^IV criteria do not include overall judgement of impairment; the two prevalence estimates are identical. 3. There is no post-traumatic stress disorder with no or mild impairment; prevalence estimate for DSM^IV criteria is 3. There is no post-traumatic stress disorder with no or mild impairment; prevalence estimate for DSM^IV criteria is used. used. comparison with patients without disorcomparison with patients without disorders, the rating on the PSC was 5.1 (95% ders, the rating on the PSC was 5.1 (95% CI 2-8) points higher for patients who only CI 2-8) points higher for patients who only had an anxiety or depressive disorder and had an anxiety or depressive disorder and 5.4 (95% CI 4-7) points higher for patients 5.4 (95% CI 4-7) points higher for patients who only had a somatoform disorder. For who only had a somatoform disorder. For the patients with comorbid somatoform the patients with comorbid somatoform and anxiety or depressive disorders the ratand anxiety or depressive disorders the rating was 10.2 points higher (95% CI 7-13), ing was 10.2 points higher (95% CI 7-13), which approximately equals the sum of the which approximately equals the sum of the increase due to the separate categories. The increase due to the separate categories. The same applied to the HADS depression scale, same applied to the HADS depression scale, whose rating increased by 4.8, 2.2 and 6.9 whose rating increased by 4.8, 2.2 and 6.9 points, respectively. For the HADS anxiety points, respectively. For the HADS anxiety scale the increase in rating in the subgroup scale the increase in rating in the subgroup with comorbid disorders (6.5) was less than with comorbid disorders (6.5) was less than the sum of the increase in the separate subthe sum of the increase in the separate subgroups (5.9 and 2.7, respectively). Funcgroups (5.9 and 2.7, respectively). 
Strengths and weaknesses Strengths and weaknesses of the study of the study
This is a comprehensive study of the prevaThis is a comprehensive study of the prevalence of strictly defined DSM-IV somatolence of strictly defined DSM-IV somatoform disorders, anxiety disorders and form disorders, anxiety disorders and depressive disorders in a consulting general depressive disorders in a consulting general practice population, with special emphasis practice population, with special emphasis on functional impairment. on functional impairment. The 59% response rate, although not The 59% response rate, although not uncommon in primary care, was fairly uncommon in primary care, was fairly low for a prevalence study. Selectivity of low for a prevalence study. Selectivity of the responding sample could, in theory, the responding sample could, in theory, invalidate our prevalence estimates. We invalidate our prevalence estimates. We addressed this issue with a detailed nonaddressed this issue with a detailed nonresponse analysis using registered data from response analysis using registered data from the RNUH-LEO database. The response the RNUH-LEO database. The response selection was independent of frequency of selection was independent of frequency of consultation and of psychological probconsultation and of psychological problems, as seen by the general practitioner. lems, as seen by the general practitioner. Response was comparatively low in the Response was comparatively low in the younger males (46%). If they were the younger males (46%). If they were the healthier subjects, this may have resulted healthier subjects, this may have resulted in some overestimation of disorders. On in some overestimation of disorders. On the other hand, social problems were the other hand, social problems were slightly underrepresented in the responding slightly underrepresented in the responding sample, which could have affected the rates sample, which could have affected the rates towards some underestimation. towards some underestimation. The exclusion of somatic disorders as a The exclusion of somatic disorders as a potential explanation of symptoms is one of potential explanation of symptoms is one of the unsolved problems in studies of somatothe unsolved problems in studies of somatoform disorders. Some form of clinical form disorders. Some form of clinical judgement will have to be involved. In the judgement will have to be involved. In the present study we adopted a cautious appresent study we adopted a cautious approach. The interviewers and the superproach. The interviewers and the supervising general practitioner made an initial vising general practitioner made an initial judgement of information provided by the judgement of information provided by the patients. If there was any doubt about the patients. If there was any doubt about the possibility of a somatic disorder as an possibility of a somatic disorder as an explanation of the presenting symptoms, explanation of the presenting symptoms, additional information was sought from additional information was sought from the general practitioner treating the patient. the general practitioner treating the patient. When doubt remained over whether a diagWhen doubt remained over whether a diagnosis of somatoform disorders was justified, nosis of somatoform disorders was justified, the symptom was regarded as 'explained'. the symptom was regarded as 'explained'. This may have resulted in an underestimaThis may have resulted in an underestimation of the prevalence of somatoform tion of the prevalence of somatoform disorders. disorders.
Prevalence estimates Prevalence estimates
When comparing our study with previous When comparing our study with previous prevalence studies, our estimates are relaprevalence studies, our estimates are relatively low. For DSM-IV somatoform distively low. For DSM-IV somatoform disorders a prevalence estimate of 30% has orders a prevalence estimate of 30% has been found (Fink been found (Fink et al et al, 1999) . For current , 1999). For current depressive disorders previous prevalence depressive disorders previous prevalence estimates were 8% (DSM-IV; Olfson estimates were 8% (DSM-IV; Olfson et et al al, 1997), 11.1-26% (DSM-III-R; Coyne , 1997), 11.1-26% (DSM-III-R; Coyne et al et al, 1994; Linzer , 1994; Linzer et al et al, 1996; Tiemens , 1996; Tiemens et et al al 1996) and 11.7% (ICD-10; Sartorius 1996) and 11.7% (ICD-10; Sartorius et et al al, 1996) . Prevalence estimates for current , 1996). Prevalence estimates for current anxiety disorders were 11.6% (DSM-IV; anxiety disorders were 11.6% (DSM-IV; Olfson Olfson et al et al, 1997), 14.4-18% (DSM-III-, 1997), 14.4-18% (DSM-III-R; Coyne R; Coyne et al et al, 1994; Linzer , 1994; Linzer et al et al, 1996; , 1996; Tiemens Tiemens et al et al, 1996) and 10.2% (ICD-10; , 1996) and 10.2% (ICD-10; Sartorius Sartorius et al et al, 1996) . Prevalences rather , 1996). Prevalences rather resembled the rates found in community resembled the rates found in community surveys, for example in Italy (Faravelli surveys, for example in Italy (Faravelli et et al al, 1997) and The Netherlands (Bijl , 1997) and The Netherlands (Bijl et al et al, , 1998) . 1998).
Our lower estimates are most likely Our lower estimates are most likely due to our strict definition of the disorders. due to our strict definition of the disorders. The SCAN interview is known as a highThe SCAN interview is known as a highthreshold diagnostic interview with a comthreshold diagnostic interview with a comparatively strong emphasis on clinically paratively strong emphasis on clinically relevant symptoms (Simon relevant symptoms (Simon et al et al, 1995; , 1995; Brugha Brugha et al et al, 2001 ). In addition, we took , 2001). In addition, we took meticulous care to rate the criterion of meticulous care to rate the criterion of functional impairment that was introduced functional impairment that was introduced in most Axis I disorders in the update from in most Axis I disorders in the update from DSM-III-R to DSM-IV. It has been de-DSM-III-R to DSM-IV. It has been demonstrated recently that adherence to clinmonstrated recently that adherence to clinical significance criteria may reduce the ical significance criteria may reduce the prevalence estimates of anxiety and depresprevalence estimates of anxiety and depressive disorders by approximately one-third sive disorders by approximately one-third (Narrow (Narrow et al et al, 2002) . Another explanation , 2002). Another explanation for our low estimates could be found in the for our low estimates could be found in the use of psychotropic medication, which may use of psychotropic medication, which may vary between populations. It is theoretivary between populations. It is theoretically possible that the prevalence rates cally possible that the prevalence rates could be reduced by 50% or more in a could be reduced by 50% or more in a population with optimal treatment. So population with optimal treatment. So far, other studies have not reported any far, other studies have not reported any figures concerning psychotropic treatment. figures concerning psychotropic treatment.
Surprisingly, no differences were found Surprisingly, no differences were found by gender for prevalence rates of anxiety by gender for prevalence rates of anxiety disorders, and gender differences for dedisorders, and gender differences for depressive disorders were minimal. This could pressive disorders were minimal. This could be due to limited statistical power, because be due to limited statistical power, because confidence limits, especially in men, were confidence limits, especially in men, were rather large. Another possibility is that rather large. Another possibility is that our emphasis on impairment contributed our emphasis on impairment contributed to this finding. For depressive disorders to this finding. For depressive disorders (but not for anxiety disorders) the gender (but not for anxiety disorders) the gender differences increased when the DSM-IV differences increased when the DSM-IV criterion of moderate to severe clinical criterion of moderate to severe clinical impairment was ignored. impairment was ignored.
Comorbidity Comorbidity
A high comorbidity of somatoform dis-A high comorbidity of somatoform disorders and anxiety or depressive disorders orders and anxiety or depressive disorders has been a common finding in previous has been a common finding in previous studies (Barsky studies (Barsky et al et al, 1992; Ormel , 1992; Ormel et al et al, , 1994; Escobar 1994; Escobar et al et al, 1998; Maier & Falkai, , 1998; Maier & Falkai, 1999) . Functional somatic syndromes are 1999). Functional somatic syndromes are also related to (but not fully dependent also related to (but not fully dependent on) anxiety and depression (Henningsen on) anxiety and depression (Henningsen et al et al, 2003) .
, 2003). Kroenke Kroenke et al et al (1997) showed that anxi-(1997) showed that anxiety disorders, depressive disorders, multiety disorders, depressive disorders, multisomatoform disorder and somatoform somatoform disorder and somatoform disorder not otherwise specified have indedisorder not otherwise specified have independent effects on functional limitations. pendent effects on functional limitations. This study confirms that the symptoms This study confirms that the symptoms and functional limitations of the disorders and functional limitations of the disorders can be summated, with the most prevalent can be summated, with the most prevalent somatoform disorders in the present study somatoform disorders in the present study being undifferentiated somatoform disorbeing undifferentiated somatoform disorder. Patients who have anxiety or depresder. Patients who have anxiety or depressive disorders are particularly limited in sive disorders are particularly limited in social functioning, role functioning because social functioning, role functioning because of emotional problems and subjective of emotional problems and subjective health. Patients with somatoform disorders health. Patients with somatoform disorders are limited in all areas that are measured by are limited in all areas that are measured by the SF-36. In patients with comorbidity the the SF-36. In patients with comorbidity the impairments are summated. impairments are summated.
Implications of the study Implications of the study
The findings on comorbidity have implicaThe findings on comorbidity have implications for the focus of treatment. To engage tions for the focus of treatment. To engage patients in treatment it is of primary impatients in treatment it is of primary importance to distinguish clearly whether portance to distinguish clearly whether the patient initially presents with psychothe patient initially presents with psychological or physical symptoms. Patients logical or physical symptoms. Patients with a somatoform presentation tend to with a somatoform presentation tend to attribute their symptoms primarily to a attribute their symptoms primarily to a physical disorder. The initial motivation physical disorder. The initial motivation for treatment of psychological symptoms for treatment of psychological symptoms will be limited. To engage subjects in a will be limited. To engage subjects in a psychologically oriented treatment the psychologically oriented treatment the somatoform presentation of symptoms somatoform presentation of symptoms should be recognised and dealt with should be recognised and dealt with (Sharpe (Sharpe et al et al, 1996; Kroenke & Swindle, , 1996; Kroenke & Swindle, 2000) . Patients might accept that psycho-2000). Patients might accept that psychological distress is a consequence of persislogical distress is a consequence of persistent somatic symptoms, or that the tent somatic symptoms, or that the relationship is circular (symptoms lead to relationship is circular (symptoms lead to distress, which, in turn, exacerbates the distress, which, in turn, exacerbates the symptoms). symptoms).
With DSM-V on the horizon, discusWith DSM-V on the horizon, discussion again has started about the classificasion again has started about the classification of somatoform disorders (Wise & tion of somatoform disorders (Wise & Birket-Smith, 2002) . It has been argued that Birket-Smith, 2002) . It has been argued that somatoform disorders are not psychiatric somatoform disorders are not psychiatric disorders in a strict sense. Indeed, it is not disorders in a strict sense. Indeed, it is not very clear that unexplained physical sympvery clear that unexplained physical symptoms are toms are caused caused by psychological factors. by psychological factors. It is clear, however, that there is a strong It is clear, however, that there is a strong relationship with anxiety and depression, relationship with anxiety and depression, given that half of the patients in general given that half of the patients in general practice with anxiety or depression suffer practice with anxiety or depression suffer from a somatoform disorder as well. The from a somatoform disorder as well. The relationship could be due to anxiety and relationship could be due to anxiety and depression causing (awareness of) physical depression causing (awareness of) physical symptoms, or physical symptoms causing symptoms, or physical symptoms causing anxiety and depression, or there may be a anxiety and depression, or there may be a more complex relationship such as a circumore complex relationship such as a circular causality. Furthermore, a third factor, lar causality. Furthermore, a third factor, such as consulting behaviour, could be such as consulting behaviour, could be related to both. In addition to patients with related to both. In addition to patients with comorbid disorders, many more patients comorbid disorders, many more patients suffer from a somatoform disorder without suffer from a somatoform disorder without anxiety or depression. From our study it is anxiety or depression. From our study it is evident that both somatoform disorders evident that both somatoform disorders and anxiety and depression come with suband anxiety and depression come with substantial functional impairment and that the stantial functional impairment and that the combination is even worse. A somatoform combination is even worse. A somatoform presentation seems to result from a compresentation seems to result from a complex interplay of perception and attribution plex interplay of perception and attribution of symptoms, resulting in unproductive illof symptoms, resulting in unproductive illness behaviour. It has been demonstrated ness behaviour. It has been demonstrated repeatedly that a cognitive-behavioural repeatedly that a cognitive-behavioural approach can be effective in alleviating this approach can be effective in alleviating this burden (Kroenke & Swindle, 2000) . The burden (Kroenke & Swindle, 2000) . The inclusion of a well-defined category of inclusion of a well-defined category of somatoform disorders in DSM-V is needed somatoform disorders in DSM-V is needed to facilitate further research on the effective to facilitate further research on the effective treatment of such patients. treatment of such patients.
Burden of illness and primary care Burden of illness and primary care
Somatoform disorders have a major impact Somatoform disorders have a major impact on the burden of psychiatric illness. At least on the burden of psychiatric illness. At least one out of six patients seen by a general one out of six patients seen by a general practitioner has a somatoform disorder. practitioner has a somatoform disorder. Furthermore, our findings demonstrate that Furthermore, our findings demonstrate that when somatoform disorders occur in comwhen somatoform disorders occur in combination with anxiety or depressive disorbination with anxiety or depressive disorders, symptoms and impairments can be ders, symptoms and impairments can be summated. To engage patients in an effecsummated. To engage patients in an effective psychological treatment it is important tive psychological treatment it is important to recognise the somatoform presentation to recognise the somatoform presentation of symptoms. General practitioners should of symptoms. General practitioners should have a strong working knowledge of the have a strong working knowledge of the principles of diagnosis and treatment of soprinciples of diagnosis and treatment of somatoform disorders, as well as of anxiety matoform disorders, as well as of anxiety and depressive disorders. and depressive disorders. Linzer, M., Spitzer, R., Kroenke, K., Linzer, M., Spitzer, R., Kroenke, K., et al et al (1996 Kroenke, K., et al et al ( ) (1996 Gender, quality of life, and mental disorders in primary Gender, quality of life, and mental disorders in primary care: results from the PRIME-MD 1000 Study. care: results from the PRIME-MD 1000 Study. Ormel, J.,Von Korff, M., Ustun, T. B., Ormel, J.,Von Korff, M., U « stu« n, T. B., et al et al (1994) 
Common mental disorders and disability across cultures. 
